国邦医药 (605507)
Guobang Pharma Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 55882.35
- Circulating A-Shares(W): 30172.22
- Earnings Per Share(RMB): 1.2100
- Net Assets Per Share(RMB): 14.8019
- Operating Revenue(W RMB): 446988.44
- Total Profit(W RMB): 77487.77
- **Net Profit Attributable to Parent(W RMB) **: 67024.26
- Net Profit Growth Rate(%): 15.78
- Weighted Return on Equity(%): 8.2400
- Operating Cash Flow Per Share(RMB): 0.7260
- Undistributed Profit Per Share(RMB): 7.1642
- Capital Reserve Per Share(RMB): 6.4558
2. Main Business
The main business covers:
- Research, development, production, and sales of related products in the pharmaceutical and animal health sectors.
3. Company Basic Information
- Company Name: Guobang Pharmaceutical Group Co., Ltd.
- Listing Date: 2021-08-02
- Industry: Pharmaceutical Manufacturing
- Address: No. 60 Xingmei Avenue, Xinchang Provincial High-tech Industrial Park, Zhejiang Province
- Website: www.gbgcn.com
- Company Profile: The company was established through the overall transformation and restructuring of Guobang Co., Ltd.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Zhejiang State-owned Capital Operation Co., Ltd. | General Legal Person | 3830.63 | 12.70 |
| 2 | Weifang Shiqi Hui Equity Investment Partnership (Limited Partnership) | General Legal Person | 2257.56 | 7.48 |
| 3 | Shaoxing Jinze Enterprise Management Co., Ltd. | General Legal Person | 687.50 | 2.28 |
| 4 | Shaoxing Shangyu State-owned Capital Investment Operation Co., Ltd. | General Legal Person | 687.50 | 2.28 |
| 5 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 551.35 | 1.83 |
| 6 | Runtu Jinheng (Jiaxing) Investment Partnership (Limited Partnership) | General Legal Person | 528.52 | 1.75 |
| 7 | Weifang Hongde Hui Equity Investment Partnership (Limited Partnership) | General Legal Person | 444.16 | 1.47 |
| 8 | Haoyu Asset Management (Beijing) Co., Ltd. - Nanjing Haoyu Hongmeng Equity Investment Partnership (Limited Partnership) | Asset Management Plan | 387.34 | 1.28 |
| 9 | Penghua Quality Governance Hybrid Securities Investment Fund (LOF) Class A | Fund | 224.09 | 0.74 |
| 10 | Penghua Industry Selection Flexible Allocation Hybrid Securities Investment Fund Class A | Fund | 116.53 | 0.39 |
5. Concept Sectors
- Helicobacter Pylori
- Synthetic Biology
- Pet Economy
- High-performing Stocks
- Share Buyback Plan
- Employee Stock Ownership
- Equity Transfer
- Below IPO Price
- Tencent Ji'an
- SSE 580
Remarks
- Data update date: 2025-09-30
- Data source: Public Market Information